WASHINGTON (Reuters) - The Chinese parent of two companies added to a U.S. economic blacklist over allegations of conducting genetic analyses used to further the repression of China's minority Uighurs has denied wrongdoing.
"BGI Group does not engage in unethical practices and does not provide gene technology for the surveillance of Uighurs. BGI Group does not condone and would never be involved in any human-rights abuses," a company statement said on Tuesday.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!